Patent · US Active

Oxoquinazolinyl-butanamide derivatives

US9901577B2 · kind B2 · utility

2Cited by

5References

9Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Dieter Dorsch · Ober-Ramstadt, DE
Hans-Peter Buchstaller · Griesheim, DE

Key dates

Filing date	Jul 10, 2014
Grant date	Feb 27, 2018
Priority date	—
Expiry date	Jul 10, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula Iin which R1-R3 and Z have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.